Where does Immundiagnostik AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immundiagnostik AG ranks #22,759 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immundiagnostik AG hold?

Immundiagnostik AG holds 12 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Immundiagnostik AG's Innovation Score?

Immundiagnostik AG has an Innovation Score of 26.5 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immundiagnostik AG focus on?

Immundiagnostik AG's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 11 patents, ranking #1,329 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Immundiagnostik AG's patent grant rate increasing or decreasing?

Immundiagnostik AG's recent grant velocity is +75% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Immundiagnostik AG's patents?

Immundiagnostik AG's patents average 8.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immundiagnostik AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immundiagnostik AG

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immundiagnostik ranks #22,759 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#22,759
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.5/100): 8.3
avg claims per patent: +75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22759 · Foreign Corporation #22,759 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,759/49,997
PHOTO-FINISH Ibotta
CPC-NARROW G01N · 7 areas
INNOV-THIN 26.5/100
CLAIMS-PAR 8.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ibotta, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immundiagnostik’s 26.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (33%) Velocity 3.3 pts (12%) Breadth 9.4 pts (35%) Claim depth 5.0 pts (19%)

Qualcomm Incorporated · highest

85
Immundiagnostik · this assignee

27
3D Lighting… · lowest

7

What this shows Immundiagnostik's Innovation Score is 26.5/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Immundiagnostik?

Each dot is one of Immundiagnostik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immundiagnostik’s own 8.3 claims/patent is at or below the 19.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Immundiagnostik vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immundiagnostik's grants concentrate

Immundiagnostik AG is a focused PatentsView assignee: 7 CPC subclasses with 91.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Immundiagnostik sits between Ibotta, Inc. and Inbicon A/S.

Immundiagnostik's three-year grant acceleration

Immundiagnostik AG shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ibotta

12
Icemos Technology

12
Ichnos Sciences

12
Ignite Enterprise…

12
Immunesensor Ther…

12
Immunwork

12
Imperial Toy

12
Inbicon A/S

12
Immundiagnostik ◀

12

What this shows Immundiagnostik holds 12 patents at rank #22,780, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immundiagnostik

By rank, the assignees closest to #22,780 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Immundiagnostik's primary technology class.

Immundiagnostik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immundiagnostik AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2017	1	8.3%
2019	2	16.7%
2020	2	16.7%
2021	2	16.7%
2022	1	8.3%
2023	1	8.3%
2024	1	8.3%
2025partial year	1	8.3%

Which technologies does Immundiagnostik AG patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

C07K - Peptides 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G06T - Image Data Processing OR Generation, IN General 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Immundiagnostik AG's patent record in context - here's where to go next.

Immundiagnostik AG's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 91.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #22,759 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immundiagnostik AG against Ibotta, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.